https://www.selleckchem.com/pr....oducts/lomeguatrib.h
an essential approach for the management of PPI-refractory GERD. Esophageal cancer (EC) ranks the eighth in morbidity and the sixth in mortality around the whole world, which is an aggressive malignancy. To authenticate potential therapeutic targets for EC is therefore imperative. Although miR-301b might display changed expression in esophageal adenocarcinoma by utilizing Taqman miRNA profiling analysis, much less is known about the impact of miR-301b in EC. By analyzing the data of 187 cancer tissues and 13 normal samples from TCGA
Like
Comment
Share
